Empire Financial Management Company’s GSK GSK Stock Holding History

Empire Financial Management Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$453K	Sell	8,212 -5,754	-41%	-$312K	0.1%	162
2025 Q4	$685K	Hold	13,966	–	–	0.15%	133
2025 Q3	$603K	Hold	13,966	–	–	0.14%	140
2025 Q2	$536K	Hold	13,966	–	–	0.15%	141
2025 Q1	$541K	Sell	13,966 -7,500	-35%	-$275K	0.17%	135
2024 Q4	$726K	Buy	21,466 +5,754	+37%	+$207K	0.23%	118
2024 Q3	$642K	Sell	15,712 -8,000	-34%	-$327K	0.2%	128
2024 Q2	$913K	Sell	23,712 -22,500	-49%	-$946K	0.3%	98
2024 Q1	$1.98M	Buy	46,212 +19,885	+76%	+$820K	0.65%	49
2023 Q4	$976K	Sell	26,327 -125	-0.5%	-$4.49K	0.38%	73
2023 Q3	$959K	Buy	26,452 +10,000	+61%	+$355K	0.42%	71
2023 Q2	$586K	Hold	16,452	–	–	0.23%	106
2023 Q1	$585K	Buy	+16,452	New	+$576K	0.24%	103

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Empire Financial Management Company's GSK Position: Q1 2026 in Review

Empire Financial Management Company reduced its GSK (GSK) stake by 41% in Q1 2026, selling an estimated $312K and leaving 8,212 shares worth $453K. The position accounts for 0.1% of the portfolio, ranked #162.

Empire Financial Management Company first reported a position in GSK in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.98M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Empire Financial Management Company held 8,212 shares of GSK worth $453K as of Q1 2026.
Empire Financial Management Company sold 5,754 GSK shares in Q1 2026, an estimated $312K.
GSK made up 0.1% of Empire Financial Management Company's portfolio in Q1 2026, its #162 holding.
Empire Financial Management Company first reported a position in GSK in Q1 2023 and has held it in 13 quarters since.
Empire Financial Management Company's GSK position peaked at $1.98M in Q1 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.